Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
Regeneron Pharmaceuticals (NASDAQ: REGN) has announced an updated presentation time for the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will now present at 7:00 a.m. ET on Monday, September 8, 2025.
The presentation will be accessible through a live webcast on Regeneron's investor relations website, with replays and transcripts remaining available for at least 30 days after the event.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha annunciato una nuova fascia oraria per la sua presentazione al Morgan Stanley 23rd Annual Global Healthcare Conference. L'intervento si terr脿 ora alle 7:00 ET di luned矛 8 settembre 2025.
La presentazione sar脿 disponibile in diretta streaming sul sito degli investor relations di Regeneron; le registrazioni e le trascrizioni resteranno accessibili per almeno 30 giorni dopo l'evento.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha anunciado un nuevo horario para su presentaci贸n en la Morgan Stanley 23rd Annual Global Healthcare Conference. La compa帽铆a presentar谩 ahora a las 7:00 a.m. ET del lunes 8 de septiembre de 2025.
La presentaci贸n podr谩 seguirse mediante una retransmisi贸n en vivo en la p谩gina de relaciones con inversores de Regeneron; las repeticiones y las transcripciones estar谩n disponibles durante al menos 30 d铆as tras el evento.
Regeneron Pharmaceuticals (NASDAQ: REGN)臧� Morgan Stanley 鞝�23須� 鞐半 旮�搿滊矊 項姢旒�鞏� 旎嵓霟办姢鞚� 氚滍憸 鞁滉皠 氤�瓴届潉 氚滍憸頄堨姷雼堧嫟. 氚滍憸電� 鞚挫牅 2025雲� 9鞗� 8鞚� 鞗旍殧鞚� 霃欕秬鞁滉皠(ET) 鞓れ爠 7:00鞐� 歆勴枆霅╇媹雼�.
氚滍憸電� Regeneron鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞁れ嫓臧� 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 鞛癌靻� 氚� 鞝勳偓氤胳潃 頄夓偓 頉� 斓滌唽 30鞚缄皠 鞝滉车霅╇媹雼�.
Regeneron Pharmaceuticals (NASDAQ: REGN) a annonc茅 une modification de l'horaire de sa pr茅sentation 脿 la Morgan Stanley 23rd Annual Global Healthcare Conference. La soci茅t茅 pr茅sentera d茅sormais 脿 7h00 ET le lundi 8 septembre 2025.
La pr茅sentation sera diffus茅e en direct via un webcast sur le site relations investisseurs de Regeneron ; les rediffusions et les transcriptions resteront disponibles pendant au moins 30 jours apr猫s l'茅v茅nement.
Regeneron Pharmaceuticals (NASDAQ: REGN) hat eine neue Pr盲sentationszeit f眉r die Morgan Stanley 23rd Annual Global Healthcare Conference bekanntgegeben. Das Unternehmen wird nun am Montag, den 8. September 2025, um 7:00 Uhr ET 辫谤盲蝉别苍迟颈别谤别苍.
Die Pr盲sentation ist 眉ber einen Live-Webcast auf der Investor-Relations-Website von Regeneron zug盲nglich; Wiedergaben und Transkripte stehen mindestens 30 Tage nach der Veranstaltung zur Verf眉gung.
- None.
- None.
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.聽(NASDAQ:聽REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at聽7:00 a.m. ET聽on聽Monday, September 8, 2025.
The presentation will be webcast live and may be accessed from the "Investors & Media" page of聽Regeneron's website at聽. Replays and transcripts of the webcast will be archived on the Company's website for at least 30 days.
础产辞耻迟听搁别驳别苍别谤辞苍
搁别驳别苍别谤辞苍听(狈础厂顿础蚕: REGN) is a leading biotechnology company that invents,聽develops聽and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to聽repeatedly and consistently translate science聽into medicine has led to numerous approved treatments and鈥痯roduct candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious聽diseases, and rare diseases.聽
Regeneron聽pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as聽VelociSuite庐, which produces optimized fully human antibodies and new classes of bispecific antibodies.鈥疻e are shaping the next frontier of medicine with data-powered insights from the鈥疪egeneron Genetics Center庐鈥痑nd pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.
For more information, please visit or follow Regeneron on , , or .
Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
听听听听听听听听
FAQ
When is Regeneron (REGN) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Regeneron's Morgan Stanley conference presentation?
How long will Regeneron's conference presentation replay be available?
What is the updated time for REGN's Morgan Stanley conference presentation?
